ADDF-Harrington supports academic investigators with research funding and drug development expertise to advance medicines for Alzheimer’s disease, related dementias, and aging-related cognitive decline.
ADDF-Harrington Scholar Program supports academic researchers with drug-development funding and expert guidance to advance novel medicines that treat, prevent, slow, or reverse Alzheimer’s and related dementias.
Drug Development RFP supports researchers and clinicians developing drugs and devices through IND-enabling studies and early clinical trials to advance treatments for Alzheimer’s disease and related dementias.
Brain Health Medicines Scholar Award supports researchers with funding and drug development expertise to advance discoveries aimed at treating, preventing or curing Alzheimer's disease and related dementias.
Accelerating Drug Discovery for Frontotemporal Degeneration supports researchers and clinicians developing small molecules and biologics to advance disease-modifying treatments for frontotemporal dementia.
Accelerating Drug Discovery for FTD supports investigators developing small molecule and biologic drugs through lead optimization and animal-model testing to advance disease-modifying treatments for FTD.